Corcept Therapeutics Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Redwood City, CA
CORT chart
What traders are saying about $CORT
Latest postsCorcept Therapeutics Inc news
- Lifyorli Sales Surge Could Reshape Corcept Therapeutics Stock Story
Simply Wall St ·
- Can You Justify Buying Corcept Stock Today?
trefis.com ·
- Corcept Therapeutics (CORT) Faces A Valuation Test As Profit Jumps And Pipeline Hopes Build
Yahoo Finance ·
- Corcept Therapeutics (CORT) Stock Trades At A Premium On Strong Q3 Earnings
Simply Wall St ·
- Corcept Therapeutics Incorporated Q3 2026 Earnings Call Summary
app.moby.co ·
- Form 4 Corcept Therapeutics Incorporated: Roberto Wandenkolk Vieira (President, Oncology) For: 2 November
Investing.com Canada ·
- Corcept Therapeutics former president Sean Maduck sells $2.05M in stock
Investing.com ·
- Corcept Therapeutics Incorporat (CORT) Stock Forecasts
Yahoo Finance ·
- 25,000 Corcept Therapeutics (CORT) shares sold under Sean Maduck’s prearranged trading plan.
Stock Titan ·
- Corcept Therapeutics Inc (CORT) (Q3 2026) Earnings Call Highlights: Revenue Surges 64% as ...
Yahoo Finance ·
- Piper Sandler maintains Corcept Therapeutics at Overweight, raises price target to $173 from $165
TradingView ·
- Corcept Therapeutics (CORT) Q3 2026 Earnings Call Transcript
fool.com ·
Corcept Therapeutics Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $761.4M | $675.0M | $482.4M | $401.9M |
| Net income | $99.7M | $141.2M | $106.1M | $101.4M |
| Diluted EPS | $0.82 | $1.23 | $0.94 | $0.87 |
| Total assets (year end) | $836.7M | $840.6M | $621.5M | $583.4M |
| Cash and equivalents (year end) | $120.5M | $127.7M | $135.6M | $66.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Corcept Therapeutics Inc
- Ticker
- CORT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Redwood City, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1088856
Frequently asked questions
What exchange is Corcept Therapeutics Inc listed on?
Corcept Therapeutics Inc trades on the Nasdaq under the ticker symbol CORT.
What industry is Corcept Therapeutics Inc in?
Corcept Therapeutics Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Corcept Therapeutics Inc headquartered?
Corcept Therapeutics Inc's business address on file with the SEC is in Redwood City, CA.
When does Corcept Therapeutics Inc's fiscal year end?
Corcept Therapeutics Inc's fiscal year ends on December 31.
How much revenue did Corcept Therapeutics Inc report?
Corcept Therapeutics Inc reported $761.4M in revenue for calendar year 2025, according to its SEC filings.